[HTML][HTML] The pediatric glucocorticoid toxicity index

P Brogan, R Naden, SP Ardoin, JC Cooper… - Seminars in Arthritis and …, 2022 - Elsevier
Objectives: To develop a Pediatric Glucocorticoid Toxicity Index (pGTI), a standardized,
weighted clinical outcome assessment that measures change in glucocorticoid (GC) toxicity over …

[HTML][HTML] Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative …

JC Cooper, K Rouster-Stevens, TB Wright, JJ Hsu… - Pediatric …, 2018 - Springer
Background To reduce treatment variability and facilitate comparative effectiveness studies,
the Childhood Arthritis and Rheumatology Research Alliance (CARRA) published …

Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood‐Onset Proliferative Lupus Nephritis

…, SE Wenderfer, JC Cooper… - Arthritis & …, 2024 - Wiley Online Library
Objective We compared clinical characteristics and renal response in patients with
childhood‐onset proliferative lupus nephritis (LN) treated with the EuroLupus versus National …

Use of EuroLupus cyclophosphamide dosing for the treatment of lupus nephritis in childhood-onset systemic lupus erythematosus in North America

…, SE Wenderfer, LB Lewandowski, JC Cooper… - The Journal of …, 2022 - jrheum.org
Objective. Childhood-onset systemic lupus erythematosus (cSLE) has higher rates of lupus
nephritis (LN) than adult-onset SLE, often requiring intensive immunosuppression. This study …

Approach to membranous lupus nephritis: a survey of pediatric nephrologists and pediatric rheumatologists

…, E Yen, DM Okamura, JC Cooper… - The Journal of …, 2017 - jrheum.org
Objective. To describe treatment practices for childhood pure membranous lupus nephritis (MLN).
Methods. Survey study of Childhood Arthritis and Rheumatology Research Alliance …

MicroRNA expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma

…, S Soneji, T Marafioti, CDO Cooper… - … journal of cancer, 2007 - Wiley Online Library
Diffuse large B cell lymphoma (DLBCL) is an aggressive malignancy that accounts for nearly
40% of all lymphoid tumors. This heterogeneous disease can be divided into germinal …

Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization

…, AP Monaco, H Lehrach, CS Cooper - Human molecular …, 1992 - academic.oup.com
A high proportion of synovial sarcomas contain a chromosome translocation t(X;18)(p11.2;q11.2).
We have previously used somatic cell hybrids derived from an established cell line, …

Cytogenetic and molecular analysis of synovial sarcoma

…, BA GUSTERSON, CS COOPER - International …, 1992 - spandidos-publications.com
We have carried out cytogenetic studies on a series of ten synovial sarcomas. Five of these
tumours contained the characteristic reciprocal translocation t (X; 18)(p11. 2; q11. 2) and a …

An atlas of genetic influences on osteoporosis in humans and mice

…, SM Vaillancourt, S Kaptoge, P Baldock, C Cooper… - Nature …, 2019 - nature.com
Osteoporosis is a common aging-related disease diagnosed primarily using bone mineral
density (BMD). We assessed genetic determinants of BMD as estimated by heel quantitative …

Efficacy of lifestyle and psychosocial interventions in reducing cognitive decline in older people: Systematic review

…, K Ritchie, J Huntley, Z Walker, C Cooper - Ageing Research …, 2020 - Elsevier
It is unclear what non-pharmacological interventions to prevent cognitive decline should
comprise. We systematically reviewed lifestyle and psychosocial interventions that aimed to …